What Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future
Metastatic breast cancer represents a diagnostic and therapeutic challenge due to tumor heterogeneity and to various physiological barriers that hinder drug delivery to the metastatic sites. To overcome these limitations, nanoformulated drugs have been developed and tested in preclinical studies, an...
Main Authors: | Truffi Marta, Sorrentino Luca, Mazzucchelli Serena, Fiandra Luisa, Corsi Fabio |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Nanomaterials |
Online Access: | http://dx.doi.org/10.1155/2016/5436458 |
Similar Items
-
Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy
by: Marta Truffi, et al.
Published: (2019-03-01) -
Emerging Therapies: What Are Promising in the Near Future?
by: Geom Seog Seo, et al.
Published: (2018-02-01) -
Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer
by: Marta Sevieri, et al.
Published: (2021-02-01) -
Indocyanine Green Nanoparticles: Are They Compelling for Cancer Treatment?
by: Marta Sevieri, et al.
Published: (2020-07-01) -
H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
by: S. Mazzucchelli, et al.
Published: (2017-08-01)